BeStock  
Stocks › Biotechnology › ANRO

Alto Neuroscience ANRO

US equityMarket cap rank #3145Biotechnology
$25.37 −$1.14 (-4.30%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.37 0.00%
Open$25.76
Prev close$26.51
Day range$24.40 – $26.48
Volume522.5K
Market cap$1.02B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$27.23M-82.1% YoY
Net profit-$25.12M-77.2% YoY
Diluted EPS-$0.54-3.8% YoY
Free cash flow-$20.76M-109.3% YoY
Operating cash flow-$20.76M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-15.2MDec '24$-15.2MMar '25$-17.7MJun '25$-14.2MSep '25$-16.2MDec '25$-26.2MMar '26$-27.6MJun '26$-25.1MSep '26

Diluted EPS by quarter

-0.56Dec '24-0.56Mar '25-0.65Jun '25-0.52Sep '25-0.45Dec '25-0.80Mar '26-0.65Jun '26-0.54Sep '26

Free cash flow by quarter

$-13.5MDec '24$-16.6MMar '25$-13.8MJun '25$-9.9MSep '25$-11.5MDec '25$-27.6MMar '26$-19.8MJun '26$-20.8MSep '26

Annual revenue

$210.0KFY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-46.6%
Return on assets-40.2%
Return on invested capital-44.5%
Current ratio18.12
Liabilities / assets9.2%
Cash & investments$319.34M
Total debt$16.65M
Net cash (debt)$302.69M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $0.00 $0.00 $0.00 – –
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $27.23M $29.13M $27.14M $66.36M $17.06M
Selling and Admin Expenses $9.06M $7.02M $6.84M $20.75M $5.06M
-General & Admin Expense $9.06M $7.02M $6.84M $20.75M $5.06M
Research & Development $18.16M $22.11M $20.29M $45.62M $12.00M
Operating Profit -$27.23M -$29.13M -$27.14M -$66.36M -$17.06M
Net Non-Operating Interest Income (Expense) $2.14M $1.62M $1.02M $4.13M $986,000.00
Non-Operating Interest Income $2.60M $2.11M $1.56M $6.60M $1.56M
Non-Operating Interest Expense $463,000.00 $491,000.00 $545,000.00 $2.47M $575,000.00
Other Income (Expense) -$36,000.00 -$130,000.00 -$115,000.00 -$1.01M -$113,000.00
Special Income (Charges) $0.00 $0.00 $0.00 -$681,000.00 $0.00
Other Non-Operating Income (Expenses) -$36,000.00 -$130,000.00 -$115,000.00 -$327,000.00 -$113,000.00
Pretax Profit -$25.12M -$27.64M -$26.24M -$63.24M -$16.18M
Net Profit -$25.12M -$27.64M -$26.24M -$63.24M -$16.18M
Profit from Continuing Operations -$25.12M -$27.64M -$26.24M -$63.24M -$16.18M
Net Income to Parent Company -$25.12M -$27.64M -$26.24M -$63.24M -$16.18M
Net Income to Common Stockholders -$25.12M -$27.64M -$26.24M -$63.24M -$16.18M
Basic EPS -$0.54 -$0.65 -$0.80 -$2.19 -$0.45
Diluted EPS -$0.54 -$0.65 -$0.80 -$2.19 -$0.45
-Less:Other Special Charges – – – $681,000.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $326.51M $254.07M $276.26M $184.69M $184.69M
Total Current Assets $323.20M $247.32M $269.13M $177.72M $177.72M
Cash and Cash Equivalents & Short-Term Investments $319.34M $243.73M $263.76M $176.48M $176.48M
-Cash and Cash Equivalents $319.34M $243.73M $263.76M $176.48M $176.48M
Prepaid Assets $3.85M $3.59M $5.36M $1.23M $1.23M
Total Non-Current Assets $3.31M $6.75M $7.13M $6.97M $6.97M
Net PPE $2.74M $5.91M $6.30M $6.13M $6.13M
-Gross PPE $4.81M $7.80M $8.00M $7.66M $7.66M
-Accumulated Depreciation -$2.06M -$1.89M -$1.71M -$1.53M -$1.53M
Other Non-Current Assets $566,000.00 $838,000.00 $838,000.00 $838,000.00 $838,000.00
Total Liabilities $29.98M $34.82M $32.89M $33.55M $33.55M
Total Current Liabilities $17.84M $16.65M $13.12M $11.33M $11.33M
Payables $3.47M $4.02M $3.37M $1.88M $1.88M
-Accounts Payable $3.47M $4.02M $3.37M $1.88M $1.88M
Current Accrued Expenses $8.48M $7.50M $6.31M $7.71M $7.71M
Short-Term Debt and Capital Lease Obligation $5.88M $5.13M $3.44M $1.74M $1.74M
-Current Debt $4.52M $3.77M $2.14M $585,000.00 $585,000.00
-Current Capital Lease Obligation $1.37M $1.36M $1.30M $1.15M $1.15M
Total Non-Current Liabilities $12.14M $18.17M $19.78M $22.22M $22.22M
Long Term Debt and Capital Lease Obligation $12.14M $18.17M $19.78M $22.22M $22.22M
-Long Term Debt $11.47M $14.88M $16.22M $18.40M $18.40M
-Long Term Capital Lease Obligation $673,000.00 $3.28M $3.56M $3.82M $3.82M
Total Equity $296.53M $219.25M $243.37M $151.14M $151.14M
Stockholders' Equity $296.53M $219.25M $243.37M $151.14M $151.14M
Capital Stock $4,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
-Common Stock $4,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
Additional Paid-In Capital $577.14M $474.74M $471.22M $352.75M $352.75M
Retained Earnings -$280.63M -$255.51M -$227.87M -$201.63M -$201.63M
Gains/Losses Not Affecting Retained Earnings $19,000.00 $17,000.00 $13,000.00 $22,000.00 $22,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$20.76M -$19.76M -$27.09M -$51.77M -$11.52M
Net cash flow from continuing operations -$20.76M -$19.76M -$27.09M -$51.77M -$11.52M
Net Income from Continuing Operations -$25.12M -$27.64M -$26.24M -$63.24M -$16.18M
Gain/Loss from Continuing Operations $8,000.00 $0.00 $9,000.00 $837,000.00 $0.00
Depreciation & Depletion & Amortization $181,000.00 $184,000.00 $184,000.00 $661,000.00 $157,000.00
Other Non-Cash Items $849,000.00 $498,000.00 $522,000.00 $1.83M $463,000.00
Change in Working Capital -$187,000.00 $3.64M -$4.39M $33,000.00 $2.10M
-Change in Prepaid Assets -$321,000.00 $1.78M -$4.13M $101,000.00 $656,000.00
-Change in Payables and Accrued Expense $134,000.00 $1.86M -$263,000.00 -$68,000.00 $1.44M
Net cash flow from investing $0.00 $0.00 -$556,000.00 -$24,000.00 $0.00
Net Cash Flow from Continuing Investing Activities $0.00 $0.00 -$556,000.00 -$24,000.00 $0.00
Capital Expenditure $0.00 $0.00 -$556,000.00 -$24,000.00 $0.00
Financing Cash Flow $96.37M -$273,000.00 $114.94M $60.08M $50.19M
Net Cash Flow from Continuing Financing Activities $96.37M -$273,000.00 $114.94M $60.08M $50.19M
Net Issuance Payments Of Debt $0.00 $0.00 $0.00 $9.48M $0.00
Net Common Stock Issuance $94.60M -$348,000.00 $115.13M $49.83M $49.83M
Proceeds from Stock Option Exercised $1.77M $75,000.00 $6,000.00 $703,000.00 $352,000.00
Ending Cash Balance $319.84M $244.23M $264.26M $176.98M $176.98M
Net Change in Cash $75.61M -$20.03M $87.29M $8.29M $38.67M
Beginning Cash Balance $244.23M $264.26M $176.98M $168.73M $138.32M
Effect of Exchange Rate Changes $2,000.00 $4,000.00 -$16,000.00 -$30,000.00 -$1,000.00
Free Cash Flow -$20.76M -$19.76M -$27.65M -$51.79M -$11.52M
Net Other Financing Charges – – -$190,000.00 $67,000.00 $0.00

Discussion

No comments yet — be the first to weigh in on ANRO.

Sign in to join the discussion.

Scroll to Top